NewsRx

Search our medical news database

Genetics & Genomics

Lexicon Genetics Changes Name to Lexicon Pharmaceuticals as Drug Development Pipeline Progresses

Published in Drug Law Weekly, May 8th, 2007

Lexicon Genetics Incorporated (NASDAQ:LEXG) announced that its proposed name change to Lexicon Pharmaceuticals, Inc. was approved by its shareholders at its annual shareholder meeting held on April 25, 2007. In connection with the name change, Lexicon is changing its common stock ticker symbol on the Nasdaq Global Market to "LXRX," which change is expected to be effective as of the opening of trading on Friday, April 27, 2007. The company is also launching a new logo and website address, which can be found at http://www.lexpharma.com/ .

Arthur T. Sands, M.D., Ph.D., Lexicon's president and chief executive officer commented, "We have made great strides this year in our...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Drug Law Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook